Dr. Rugo Discusses Immunotherapy in TNBC – OncLive
|
Dr. Rugo Discusses Immunotherapy in TNBC
OncLive Hope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center, discusses immunotherapy in triple-negative breast cancer (TNBC). Immunotherapy agents need to be … |
